期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Effects of binder components and PVA modifier on bonding performance of phosphate binder for sand core-making
1
作者 Wei-hua Liu Xin Jia +1 位作者 Lai Song Ying-min Li 《China Foundry》 SCIE CAS CSCD 2023年第2期134-138,共5页
A type of heat-curing phosphate binder was proposed,and orthogonal experiments based on the tensile strength of sand samples determined that the optimal composition of the binder was phosphoric acid:water:aluminum hyd... A type of heat-curing phosphate binder was proposed,and orthogonal experiments based on the tensile strength of sand samples determined that the optimal composition of the binder was phosphoric acid:water:aluminum hydroxide:magnesium oxide:boric acid=300:70:60:9:8.Adding 10%polyvinyl alcohol(PVA)solution during the sand mixture process can significantly improve the 24 h tensile strength of sand samples.When adding 30 g phosphate binder and 8 g 10%PVA solution,the initial tensile strength of the sample is 0.76 MPa,the room temperature tensile strength is 2.29 MPa,and the 24 h tensile strength is 1.73 MPa.The heat-curing modified phosphate sand mold has high tensile strength and low gas generation,which can meet general casting production requirements. 展开更多
关键词 phosphate binder heat curing MODIFIER tensile strength
下载PDF
Chitosan: A Desirable Candidate for Treating Hyperphosphatemia?
2
作者 Haisong Zhang Meng Yu Hailei Zhang 《Journal of Pharmacy and Pharmacology》 2016年第2期99-104,共6页
Non-absorbed macromolecular binders as sequestrants for phosphate ions offer an effective approach to treat hyperphosphatemia in ESRD (end-stage renal disease) patients. RenaGel has been an example with remarkable s... Non-absorbed macromolecular binders as sequestrants for phosphate ions offer an effective approach to treat hyperphosphatemia in ESRD (end-stage renal disease) patients. RenaGel has been an example with remarkable success of a polymer synthesized to prevent the absorption of dietary phosphate for ESRD patients. Electrostatic interaction is the primary driving force for complexation of phosphate-based anions with these amino groups in the polymer backbone. Chitosan is a deacetylation product of chitin, which is the structural element in the exoskeleton of crustaceans and cell walls of fungi. The amino groups in the backbone give the phosphate binding ability to chitosan. This article has demonstrated that chitosan exhibited a phosphate binding effect indeed. Thus, it has potential applications in environmental management and wastewater treatment, as well as treatment of hyperphosphatemia patients. 展开更多
关键词 CHITOSAN phosphate binder hyperphosphatemia.
下载PDF
Vascular calcification:When should we interfere in chronic kidney disease patients and how? 被引量:10
3
作者 Usama Abdel Azim Sharaf El Din Mona Mansour Salem Dina Ossama Abdulazim 《World Journal of Nephrology》 2016年第5期398-417,共20页
Chronic kidney disease (CKD) patients are endangered with the highest mortality rate compared to other chronic diseases. Cardiovascular events account for up to 60% of the fatalities. Cardiovascular calcifcations af... Chronic kidney disease (CKD) patients are endangered with the highest mortality rate compared to other chronic diseases. Cardiovascular events account for up to 60% of the fatalities. Cardiovascular calcifcations affect most of the CKD patients. Most of this calcification is related to disturbed renal phosphate handling. Fibroblast growth factor 23 and klotho defciency were incriminated in the pathogenesis of vascular calcification through different mechanisms including their effects on endothelium and arterial wall smooth muscle cells. In addition, deficient klotho gene expression, a constant feature of CKD, pro-motes vascular pathology and shares in progression of the CKD. The role of gut in the etio-pathogenesis of systemic infammation and vascular calcifcation is a newly discovered mechanism. This review will cover the medical history, prevalence, pathogenesis, clinical relevance, different tools used to diagnose, the ideal timing to prevent or to withhold the progression of vascular cal-cification and the different medications and medical procedures that can help to prolong the survival of CKD patients. 展开更多
关键词 Chronic kidney disease UREMIA Calcifcation SEVELAMER Calcific uremic arteriolopathy Fibroblast growth factor 23 KLOTHO phosphate binders Kidney transplantation
下载PDF
FGF23 and inflammation
4
作者 Usama AA Sharaf El Din Mona M Salem Dina O Abdulazim 《World Journal of Nephrology》 2017年第1期57-58,共2页
Systemic infammation is a recognized feature in chronic kidney disease (CKD). The role of systemic infammation in the pathogenesis of vascular calcifcation was recently settled. FGF23 was recently accused as a direc... Systemic infammation is a recognized feature in chronic kidney disease (CKD). The role of systemic infammation in the pathogenesis of vascular calcifcation was recently settled. FGF23 was recently accused as a direct stimulus of systemic inflammation. This finding explains the strong association of FGF23 to vascular calcifcation and increased mortality among CKD. 展开更多
关键词 Chronic kidney disease Infammation Vascular calcifcation FGF23 phosphate binders
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部